Inventiva (IVA) Change in Cash (2019 - 2024)

Inventiva (IVA) posted quarterly Change in Cash of -$18.2 million for Q2 2024, down 41.97% quarter-over-quarter from -$12.8 million in Q4 2022.

Inventiva (IVA) Change in Cash (2019 - 2024) Analysis & Trends

Inventiva's Change in Cash history runs 5 years deep, the most recent figure standing at -$18.2 million for Q2 2024.

In Q2 2024, Change in Cash changed N/A year-over-year to -$18.2 million; the TTM figure through Jun 2024 stood at -$61.2 million (changed N/A YoY), while the FY2025 annual figure was $3.7 million, down 94.88% from the prior year.
Change in Cash for Q2 2024 stood at -$18.2 million, down from -$12.8 million in the prior quarter.
The five-year high for Change in Cash was $19.6 million in Q4 2020, with the low at -$18.2 million in Q2 2024.
The 4-year median for Change in Cash is -$12.8 million (2022), against an average of -$4.6 million.
The sharpest annual moves came in 2020 and 2021: Change in Cash soared 190.19% in 2020, then plunged 376.32% in 2021.
Inventiva's Change in Cash stood at $19.6 million in 2020, then plunged by 187.7% to -$17.2 million in 2021, then grew by 25.56% to -$12.8 million in 2022, then slumped by 41.97% to -$18.2 million in 2024.
Business Quant data shows IVA's Change in Cash at -$18.2 million in Q2 2024, -$12.8 million in Q4 2022, and -$13.1 million in Q3 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Cash (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	649.20 Mn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	-504.60 Mn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	374.50 Mn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	427.25 Mn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-1.97 Mn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	225.59 Mn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-2.94 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	-37.42 Mn
10	Inventiva	888.89 Mn	888.89 Mn	-	-

Download Data